Iberdrola Renewables offers 92 cents per Infigen (ASX:IFN) stapled security

  • Home
  • Company News
  • Iberdrola Renewables offers 92 cents per Infigen (ASX:IFN) stapled security
16Sep

Iberdrola Renewables offers 92 cents per Infigen (ASX:IFN) stapled security

 

Iberdrola Renewables Australia announced that its offer price of 92 cents per Infigen (ASX:IFN) Stapled Security in relation to its offmarket takeover offer is its best and final offer.

The Iberdrola Offer will remain open for acceptance until 7.00pm (Sydney, Australia time) on Wednesday, 23 September 2020, unless further extended. 

Before yesterday, Iberdrola’s voting power in Infigen was 97.7 per cent. 

Infigen’s Independent Directors urge investors to accept the Iberdrola Offer without delay.

Shares in Infigen (ASX:IFN) are steady at 93 cents.

Copyright 2020 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

07Aug

Stocks of the Hour: REA Group, ResMed & News Corp

06 Aug 2021 - A snapshot of some of the news that broke today, featuring REA Group (ASX:REA), ResMed (ASX:RMD) & News Corp (ASX:NWS).

Read More
11Sep

APN Funds Management buys Queensland warehouse

11 Sep 2019 - APN Funds Management (ASX:ADI), as Responsible Entity and Manager of APN Industria REIT is pleased to announce the acquisition of a Queensland warehouse for $18.34 million, representing an initial yield of 8 per cent.

Read More
22Apr

Stocks of the Hour: OZ Minerals, Chimeric Therapeutics, AGL Energy

22 Apr 2021 - A snapshot of the top news for the hour featuring OZ Minerals, Chimeric Therapeutics, AGL Energy.

Read More
17Aug

Stocks of the Hour: Nuheara, Frontier Energy, XTEK

17 Aug 2022 - A snapshot of the stocks on the move featuring Nuheara (ASX:NUH), Frontier Energy (ASX:FHE) and XTEK (ASX:XTE).

Read More
01Jun

Mesoblast’s REMESTEMCEL-L “significantly improved outcomes” in patients with inflammatory lung disease and COVID-19

01 Jun 2020 - Mesoblast (ASX:MSB) says its lead mesenchymal stem cell (MSC) product candidate remestemce-L treatment showed significantly improved outcomes for patients with chronic obstructive pulmonary disease (COPD).

Read More
22Jul

QBE Insurance Group (ASX:QBE) flags $750m loss for 1H20

22 Jul 2020 - Insurance group QBE (ASX:QBE) has flagged a $750 million net statutory loss after tax for the first half of the year (1H20) primarily due to Covid.

Read More
30May

Stocks of the Hour: Telix Pharmaceuticals, Australian Unity Office Fund & Yancoal

30 May 2022 - A snapshot of the stocks on the move featuring Telix Pharmaceuticals (ASX:TLX), Australian Unity Office Fund (ASX:AOF) & Yancoal (ASX:YAL).

Read More
21Sep

ZipCo (ASX:Z1P) appoints Pippa Downes to the board

21 Sep 2020 - Zip Co (ASX: Z1P) has today announced changes to its Board of Directors, with the retirement of Ms Dianne Challenor and the appointment of Ms Pippa Downes.

Read More
16Jul

Beacon Lighting Group (ASX:BLX) report full year profit growth of 16.7%

16 Jul 2020 - Beacon Lighting Group (ASX:BLX) report underlying Net Profit After Tax rose to $19 million, a profit growth of around 16.7 per cent.

Read More
12Mar

Elixir Energy (ASX:EXR) struggles as Mongolia coal seam gas exploration continues

12 Mar 2021 - Gas exploration player, Elixir Energy (ASX:EXR) has reported a net loss after tax of over $990,000 for the half year ended 31 December 2020.

Read More